These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 39504245)

  • 21. A monoclonal antibody targeting the Nipah virus fusion glycoprotein apex imparts protection from disease.
    Avanzato VA; Bushmaker T; Oguntuyo KY; Yinda CK; Duyvesteyn HME; Stass R; Meade-White K; Rosenke R; Thomas T; van Doremalen N; Saturday G; Doores KJ; Lee B; Bowden TA; Munster VJ
    J Virol; 2024 Oct; 98(10):e0063824. PubMed ID: 39240113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results.
    Wing K; Williamson E; Carpenter JR; Wise L; Schneeweiss S; Smeeth L; Quint JK; Douglas I
    Health Technol Assess; 2021 Aug; 25(51):1-70. PubMed ID: 34463610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel orf virus vector-based COVID-19 booster vaccine shows cross-neutralizing activity in the absence of anti-vector neutralizing immunity.
    Klinkardt U; Schunk M; Ervin J; Schindler C; Sugimoto D; Rankin B; Amann R; Monti M; Kutschenko A; Schumacher C; Huber K; Zeder A; Heikkila N; Didierlaurent AM; Schwarz SE; Derouazi M
    Hum Vaccin Immunother; 2024 Dec; 20(1):2410574. PubMed ID: 39397784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Key to Increase Immunogenicity of Next-Generation COVID-19 Vaccines Lies in the Inclusion of the SARS-CoV-2 Nucleocapsid Protein.
    Mendoza-Ramírez NJ; García-Cordero J; Shrivastava G; Cedillo-Barrón L
    J Immunol Res; 2024; 2024():9313267. PubMed ID: 38939745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination.
    Tang J; Zeng C; Cox TM; Li C; Son YM; Cheon IS; Wu Y; Behl S; Taylor JJ; Chakaraborty R; Johnson AJ; Shiavo DN; Utz JP; Reisenauer JS; Midthun DE; Mullon JJ; Edell ES; Alameh MG; Borish L; Teague WG; Kaplan MH; Weissman D; Kern R; Hu H; Vassallo R; Liu SL; Sun J
    Sci Immunol; 2022 Oct; 7(76):eadd4853. PubMed ID: 35857583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of a SARS-CoV-2 mRNA booster immunization containing additional antigens to a spike-based mRNA vaccine against Omicron BA.5 infection in hACE2 mice.
    Hurst JR; Naghibosadat M; Budowski P; Liu J; Samaan P; Budiman F; Kurtesi A; Qi F; Menon H; Krishnan R; Abioye J; Gingras AC; Ostrowski M; Orozco NM; Kozak RA
    PLoS One; 2024; 19(12):e0314061. PubMed ID: 39625929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of a Novel Public Antibody Lineage Correlated With Inactivated SARS-CoV-2 Vaccine and the Resultant Neutralization Activity.
    Wang J; Ni S; Chen Q; Wang C; Liu H; Huang L; Nasir MW; Wang W; Zhang X; Wu J; Liu Z; Wu J; Zhang L; Gao Y
    J Med Virol; 2024 Dec; 96(12):e70073. PubMed ID: 39610345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Australia in 2030: what is our path to health for all?
    Backholer K; Baum F; Finlay SM; Friel S; Giles-Corti B; Jones A; Patrick R; Shill J; Townsend B; Armstrong F; Baker P; Bowen K; Browne J; Büsst C; Butt A; Canuto K; Canuto K; Capon A; Corben K; Daube M; Goldfeld S; Grenfell R; Gunn L; Harris P; Horton K; Keane L; Lacy-Nichols J; Lo SN; Lovett RW; Lowe M; Martin JE; Neal N; Peeters A; Pettman T; Thoms A; Thow AMT; Timperio A; Williams C; Wright A; Zapata-Diomedi B; Demaio S
    Med J Aust; 2021 May; 214 Suppl 8():S5-S40. PubMed ID: 33934362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "I've Spent My Whole Life Striving to Be Normal": Internalized Stigma and Perceived Impact of Diagnosis in Autistic Adults.
    Huang Y; Trollor JN; Foley KR; Arnold SRC
    Autism Adulthood; 2023 Dec; 5(4):423-436. PubMed ID: 38116050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A broadly neutralizing human monoclonal antibody generated from transgenic mice immunized with HCMV particles limits virus infection and proliferation.
    Atanasoff KE; Parsons AJ; Ophir SI; Lurain N; Kraus T; Moran T; Duty JA; Tortorella D
    J Virol; 2024 Jul; 98(7):e0021324. PubMed ID: 38832789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of previous COVID-19 exposure and vaccine type (CoronaVac, ChAdOx1 nCov-19 or BNT162b2) on antibody and cytokine (Th1 or Th2) responses.
    Padilla-Bórquez DL; Matuz-Flores MG; Hernández-Bello J; Rosas-Rodríguez JA; Turrubiates-Hernández FJ; García-Arellano S; González-Estevez G; Ceja-Galvez HR; Oregon-Romero E; López-Reyes A; Muñoz-Valle JF
    Hum Vaccin Immunother; 2024 Dec; 20(1):2394265. PubMed ID: 39246041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody response to SARS-CoV-2 mRNA vaccination in Danish adults exposed to perfluoroalkyl substances (PFASs): The ENFORCE study.
    Timmermann A; Johansen IS; Tolstrup M; Heilmann C; Budtz-Jørgensen E; Tolstrup JS; Nielsen F; Grandjean P
    Environ Res; 2024 Dec; 263(Pt 1):120039. PubMed ID: 39326653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ad26.COV2.S prevents upregulation of SARS-CoV-2 induced pathways of inflammation and thrombosis in hamsters and rhesus macaques.
    Aid M; Vidal SJ; Piedra-Mora C; Ducat S; Chan CN; Bondoc S; Colarusso A; Starke CE; Nekorchuk M; Busman-Sahay K; Estes JD; Martinot AJ; Barouch DH
    PLoS Pathog; 2022 Apr; 18(4):e1009990. PubMed ID: 35395058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD007807. PubMed ID: 32851663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Display of Native SARS-CoV-2 Spike on Mammalian Cells to Measure Antibody Affinity and ADCC.
    Wilen RE; Nguyen AW; Qerqez AN; Maynard JA
    Bio Protoc; 2024 Nov; 14(22):e5119. PubMed ID: 39600972
    [No Abstract]   [Full Text] [Related]  

  • 37. Host immune responses associated with SARS-CoV-2 Omicron infection result in protection or pathology during reinfection depending on mouse genetic background.
    Singh G; Warang P; García-Bernalt Diego J; Chang L; Bykov Y; Singh S; Pache L; Cuadrado-Castano S; Webb B; Garcia-Sastre A; Schotsaert M
    Res Sq; 2023 Nov; ():. PubMed ID: 38077015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bispecific antibodies targeting two glycoproteins on SFTSV exhibit synergistic neutralization and protection in a mouse model.
    Chang Z; Gao D; Liao L; Sun J; Zhang G; Zhang X; Wang F; Li C; Oladejo BO; Li S; Chai Y; Hu Y; Lu X; Xiao H; Qi J; Chen Z; Gao F; Wu Y
    Proc Natl Acad Sci U S A; 2024 Jun; 121(24):e2400163121. PubMed ID: 38830098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel HBc-S230 protein chimeric VLPs induced robust immune responses against SARS-CoV-2.
    Feng W; Chen Z; Wu L; Chen X; Li Q; Xiang Y; Guo Y; Du W; Chen J; Zhu S; Dong H; Xue X; Zhao KN; Zhang L
    Int Immunopharmacol; 2024 Dec; 143(Pt 2):113362. PubMed ID: 39426233
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.